You are here

Aridis Pharmaceuticals, Inc.

Company Information
Address
983 University Ave Bldg B
Los Gatos, CA 95032-7637
United States



Information

UEI: LA2ZAQNZE6W5

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Stable Vaccines Delivered on Oral Thin Films

    Amount: $566,303.00

    DESCRIPTION provided by applicant Our goal is to develop a vaccine that is stable at ambient conditions and to incorporate the vaccine into an effective dosage presentation that can facilitate sto ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  2. Human Monoclonal Antibody To Treat P. aeruginosa Infections in Cystic Fibrosis

    Amount: $2,922,383.00

    DESCRIPTION (provided by applicant): Over the past two decades, the number of new antimicrobials being developed has experienced a greater than 60% decline, while the number of antibiotic resistant mi ...

    STTRPhase II2011Department of Health and Human Services National Institutes of Health
  3. Inhalable Gallium Nitrate Anti-Infective Powder for CF

    Amount: $599,829.00

    DESCRIPTION (provided by applicant): Cystic Fibrosis (CF) is an autosomal recessive disorder, which leads to the abnormal composition and physical properties of airway secretions in CF patients. Addit ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  4. Human Monoclonal Antibody To Treat P. aeruginosa Infections in Cystic Fibrosis

    Amount: $299,997.00

    DESCRIPTION (provided by applicant): Cystic Fibrosis (CF) is an autosomal recessive disorder, which leads to the abnormal composition and physical properties of airway secretions in CF patients. Addit ...

    STTRPhase I2007Department of Health and Human Services National Institutes of Health
  5. Live, oral, heat Stable S. typhi TY21a vaccine

    Amount: $974,606.00

    DESCRIPTION (provided by applicant): Vaccines represent a proven and effective approach for assuring widespread protection of large populations and can be used to reduce the number of susceptible ind ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government